NCT06904755View on ClinicalTrials.gov

Safety and Effectiveness of Mesenchymal Stem Cells in Blood Purification for the Treatment of Liver Failure

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 23, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 30, 2026

Conditions
Liver Failure
Interventions
DEVICE

It is loaded with a mesenchymal stem cells reaction device for blood purification

Artificial liver blood purification therapy is performed using a mesenchymal stem cells reactor.

Trial Locations (1)

510000

RECRUITING

Zhujiang hospital, Guangzhou

All Listed Sponsors
lead

Kebo Zhong

OTHER